✦ LIBER ✦

Monoclonal Antibody TB-403: A First-in-Human, Phase I, Double-Blind, Dose Escalation Study Directed Against Placental Growth Factor in Healthy Male Subjects

✍ Scribed by Titti Martinsson-Niskanen; Rikke Riisbro; Leonard Larsson; Lena Winstedt; Yvonne Stenberg; Steve Pakola; Jean-Marie Stassen; Steven Glazer

Book ID: 113544466
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 319 KB
Volume: 33
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2011.08.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Pharmacokinetic and Pharmacodyna

Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors

✍ Paz-Ares, L. G.; Gomez-Roca, C.; Delord, J.-P.; Cervantes, A.; Markman, B.; Corr 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB